US Broker Ratings

agilon health, inc. (AGL) Stock Analysis: Navigating the Healthcare Market with a 25% Downside

Investors looking at agilon health, inc. (AGL) are navigating a complex landscape marked by both challenges and potential opportunities. As a player in the Medical Care..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring an 80% Upside Potential in the Biotech Arena

For investors navigating the competitive landscape of the biotechnology sector, Mineralys Therapeutics, Inc. (NASDAQ: MLYS) presents an intriguing opportunity. This Radnor, Pennsylvania-based company is making significant..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Strong Growth Potential with an 11.7% Upside

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a Canadian biopharmaceutical company, is making waves in the healthcare sector with its promising therapies for autoimmune diseases. Focused on addressing..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating a Pioneering Path in Health Information Services

10x Genomics, Inc. (NASDAQ: TXG), a leader in the health information services industry, is a company worth examining for investors interested in innovative technologies that drive..

Adaptive Biotechnologies (ADPT) Stock Analysis: Revenue Growth Signals Strong Potential in Diagnostics & Research

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a prominent player in the healthcare sector, has been making significant waves in the diagnostics and research industry. Headquartered in Seattle,..

Mesoblast Limited (MESO) Stock Analysis: Unlocking a 140% Upside Potential for Investors

Mesoblast Limited (NASDAQ: MESO), a leading player in the biotechnology sector, has garnered significant attention from investors, thanks to its innovative approach to regenerative medicine. With..

Arcutis Biotherapeutics (ARQT) Stock Analysis: Riding High on a 24% Potential Upside

Investors looking for opportunities in the biotechnology sector might turn their attention to Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a company making waves with its innovative dermatological..

NeoGenomics, Inc. (NEO) Stock Analysis: Unveiling a 27.68% Potential Upside in the Diagnostics Sector

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the healthcare sector, stands out in the diagnostics and research industry. With a market capitalization of $1.71 billion,..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Evaluating a 16.78% Potential Upside for Investors

Healthcare Services Group, Inc. (NASDAQ: HCSG) stands as a significant player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Bensalem, Pennsylvania,..

Wave Life Sciences Ltd. (WVE) Stock Analysis: A Potential 270% Upside in the Biotech Arena

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based clinical-stage biotechnology company, is drawing significant attention from the healthcare investment community, with a striking potential upside of..

Integra LifeSciences Holdings C (IART) Stock Analysis: Evaluating a Resilient Contender in the Medical Devices Sector

Investors exploring opportunities in the healthcare sector may want to take a closer look at Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 69% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a prominent player in the healthcare sector specializing in medical devices for diabetes management, is currently making waves with its..

MiMedx Group, Inc (MDXG) Stock Analysis: A Promising Potential Upside of Nearly 55% in the Healthcare Sector

MiMedx Group, Inc (NASDAQ: MDXG), a leader in the biotechnology sector, is drawing significant attention from investors with its innovative approach in the healthcare industry. Specializing..

Evolent Health, Inc. (EVH) Stock Analysis: Exploring a Potential 59% Upside in the Healthcare Sector

Evolent Health, Inc. (NYSE: EVH) stands out in the healthcare sector as a company that is navigating the dynamic landscape of health information services. With a..

NovoCure Limited (NVCR): Investor Outlook and Potential 59% Upside Amidst Innovative Oncology Solutions

NovoCure Limited (NASDAQ: NVCR) stands at the forefront of medical innovation with its pioneering work in developing Tumor Treating Fields (TTFields) devices designed to combat solid..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Unveiling a 108.65% Potential Upside in the Biotechnology Sector

For investors navigating the dynamic waters of the biotechnology sector, Beam Therapeutics Inc. (NASDAQ: BEAM) presents a compelling opportunity. With its innovative approach to precision genetic..

Novavax, Inc. (NVAX) Investor Outlook: Can This Biotech Stock’s 88% Potential Upside Drive Your Portfolio?

For investors with an eye on the biotechnology sector, Novavax, Inc. (NVAX) presents a fascinating case of potential opportunity amidst volatility. Based in Gaithersburg, Maryland, Novavax..

AdaptHealth Corp. (AHCO) Stock Report: A 29% Upside Potential with Strong Buy Ratings

AdaptHealth Corp. (NASDAQ: AHCO) stands as a promising player in the healthcare sector, specifically within the medical devices industry. With a current market capitalization of $1.49..

MannKind Corporation (MNKD) Stock Analysis: A Biotech Leader with 95% Potential Upside

MannKind Corporation (NASDAQ: MNKD) is making waves in the biotechnology sector, presenting an intriguing prospect for investors seeking high-growth opportunities in healthcare. With a market capitalization..

The Pennant Group, Inc. (PNTG) Stock Analysis: A Healthcare Gem with 8.85% Potential Upside

The Pennant Group, Inc. (NASDAQ: PNTG) has captured the attention of investors, particularly those focused on the healthcare sector, due to its robust growth and compelling..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds